BDBM317141 US9617269, Compound WYQ-90-L
SMILES: COc1ccc(NC(=O)C(C)Nc2nc3n(ncc3c(=O)[nH]2)C2CCCC2)cc1
InChI Key:
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphodiesterase 9A (Homo sapiens (Human)) | BDBM317141 (US9617269, Compound WYQ-90-L) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sun Yat-Sen University; University of North Carolina at Chapel Hill US Patent | Assay Description Inhibition activities of all the N-substituted pyrazolo [3,4-d] pyrimidine ketone compounds according to the present invention to the phosphodiestera... | US Patent US9617269 (2017) BindingDB Entry DOI: 10.7270/Q2RX9F4B | |||||||||||
More data for this Ligand-Target Pair |